There is NO WAY this Brain Bleeding infused drug should be approved. Yet, the news media makes it sound as if this is a promising therapy. No doctor in their right mind would inflict this on their patents. How could you give patients a treatment with horrific potential side effects for a negligible benefit? Yet, Cramer this morning was suggesting that because the best results were from those with early stage AD that perhaps the drug could be started when patients were in their 40's. (Yet, BIIB stock gained nearly $2 billion in market cap today.)